1-4 of 4
health service demonstration project
Close
Sort by
Journal Articles

Hematologic Cancers More Costly and Have Fewer Savings Options Than Solid Tumors Under the OCM

James Baumgardner, PhD, Ahva Shahabi, PhD, Mark T Linthicum, MPP, Seanna Vine, MPH, Christopher Zacker, RPh, PhD, Darius N Lakdawalla, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4713.
https://doi.org/10.1182/blood.V130.Suppl_1.4713.4713
Published: 2017
Journal Articles

Using Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest

Lisa Marie Shook, MA, MCHES, Christina Bennett Farrell, MPH, Karen A. Kalinyak, MD, Stephen C Nelson, MD, Brandon M. Hardesty, MD, Angeli Rampersad, MD, Kay Linn Saving, MD, Wanda Witten-Shurney, Julie Panepinto, Trisha Calabrese, MPH, Lori E. Crosby, PsyD, Russell E. Ware, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5923.
https://doi.org/10.1182/blood.V128.22.5923.5923
Published: 2016
Journal Articles

Thalidomide-Associated Thromboembolism in Cancer: Reimbursement for Thalidomide’s “Off-Label” Prescribing under the 2004 Medicare Oral Pharmaceutical Demonstration Project Raises Concerns.

Andrew M. Evens, DO, MS, June M. McKoy, MD, MPH, JD, Paul R. Yarnold, PhD, Kathyrn McCaffrey, BA, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2005) 106 (11): 2244.
https://doi.org/10.1182/blood.V106.11.2244.2244
Published: 2005
Journal Articles

FDA Policies Should Be Amended To Allow Pharmaceutical Manufacturers To Disseminate Information Regarding Potentially Fatal Toxicities That Occur with Off-Label Use of Oncology Agents: A Policy Recommendation Based on Review of Thalidomide-Associated Thromboembolism Cases by the RADAR Project.

Andrew M. Evens, DO, Martin S. Tallman, MD, Seema Singhal, MD, June M. McKoy, MD, JD, E. Allison Lyons, BA, Dennis W. Raisch, PhD, Paul R. Yarnold, PhD, Hau Kwaan, MD, Timothy M. Kuzel, MD, Jayesh Mehta, MD, Charles L. Bennett, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 265.
https://doi.org/10.1182/blood.V104.11.265.265
Published: 2004